Drugs / PRGFs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00728611 | Jan 2008 → Feb 2009 | osteoarthritis, knee | Meir Medical Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRGFs | “Our aim is to examine the effect of a platelet-derived preparation rich in growth factors (PRGFs) in OA knee” NCT00728611 ↗ |
| Known as | PRGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00728611 ↗ |
| Modality | Protein / enzyme biologic | “Autologous platelet-secreted growth factors (GFs)” NCT00728611 ↗ |
| Route | Other | “intra auricular injection 6mg” NCT00728611 ↗ |